Allen Ray Sing Chen MD PhD, MHS

Pediatric Hematology & Oncology•Baltimore, MD

Pediatric Hematologic Oncology, Pediatric Solid Tumor Oncology

Associate Professor of Oncology, Associate Professor of Pediatrics, Johns Hopkins University School of Medicine; Vice Chair, Quality, Safety, and Service, Oncology; Health IT Patient Safety Officer, Armstrong Institute for Patient Safety and Quality

Join to View Full Profile

1800 Orleans StreetBloomberg 11NBaltimore, MD 21287
Phone+1 410-955-8751
Fax+1 410-614-1802

Education & Training

University of WashingtonFellowship, Pediatric Hematology/Oncology, 1989 - 1993
University of WashingtonResidency, Pediatrics, 1986 - 1989
Duke University School of MedicineClass of 1986

Certifications & Licensure

MD State Medical License 1995 - 2026
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

America's Top Doctors for Cancer Castle Connolly, 2005-2017
America's Top Doctors Castle Connolly, 2004-2017
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
Top Doctors:Baltimore Area Castle Connolly, 2012
Top Doctors:Washington-Baltimore Castle Connolly, 2012
Super Doctor SuperDoctors.com
Join now to see all

Clinical Trials

Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid Tumors Start of enrollment: 1997 May 31
Completed
Phase 1
Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma Start of enrollment: 2001 Oct 18
ACTIVE_NOT_RECRUITING
PHASE3
Immunotherapy Using Cyclosporine, Interferon Gamma, and Interleukin-2 After High-Dose Myeloablative Chemotherapy With Autologous Stem Cell Transplantation in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma Start of enrollment: 2003 Nov 01
Completed
Phase 2, Phase 3
Transplantation of Umbilical Cord Blood Following Chemotherapy for Blood Cancers Start of enrollment: 2007 Dec 20
Terminated
Phase 1, Phase 2
Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma Start of enrollment: 2000 Nov 06
Recruiting
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RECRUITING
MRD Testing Before and After Hematopoietic Cell Transplantation for Pediatric Acute Myeloid Leukemia Start of enrollment: 2011 Oct 01
Completed
Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Dinutuximab in Treating Younger Patients With Refractory or Relapsed Neuroblastoma Start of enrollment: 2013 Feb 12
Completed
Phase 2
Brentuximab Vedotin and Gemcitabine Hydrochloride in Treating Younger Patients With Relapsed or Refractory Hodgkin Lymphoma Start of enrollment: 2013 Jan 31
Completed
Phase 1, Phase 2
Chlorhexidine Gluconate Cleansing in Preventing Central Line Associated Bloodstream Infection and Acquisition of Multi-drug Resistant Organisms in Younger Patients With Cancer or Undergoing Donor Stem Cell Transplant Start of enrollment: 2013 Nov 04
Completed
Phase 3
Busulfan, Cyclophosphamide, and Melphalan or Busulfan and Fludarabine Phosphate Before Donor Hematopoietic Cell Transplant in Treating Younger Patients With Juvenile Myelomonocytic Leukemia Start of enrollment: 2013 Jun 24
Completed
Phase 2
Myeloablative Haploidentical BMT With Post-transplant Cyclophosphamide for Pediatric Patients With Hematologic Malignancies Start of enrollment: 2015 Jul 02
Completed
Phase 2
Treatment of Rapid Onset Obesity, Hypoventilation, Hypothalamic Dysfunction, and Autonomic Dysregulation (ROHHAD ) Start of enrollment: 2015 Mar 01
Withdrawn
Not Applicable
Join now to see all

Publications & Presentations

PubMed

1 citations
Understanding the Information Needs of Pharmacy Staff Using CancelRx: A Qualitative Study of the Use of Prescription-cancellation.
Vanessa B Hurley, Elaine Giletta, Yushi Yang, Nicole L Mollenkopf, Rabia Jalalzai
Exploratory Research in Clinical and Social Pharmacy. 2024-03-01
1 citations
Pharmacy e-Prescription Dispensing Before and After CancelRx Implementation.
Samantha I Pitts, Sarah Olson, Lisa R Yanek, Nae-Yuh Wang, Taylor Woodroof
JAMA Internal Medicine. 2023-10-01
1 citations
Cell Therapy Informatics: Updates on the Integration of HCT/IEC Functionalities into an Electronic Medical Record System in the US to Promote Efficiency, Patient Safet...
Vincent T Ho, Thomas R Klumpp, Wayne H Liang, Matt Prestegaard, Mitchell Horwitz
Transplantation and Cellular Therapy. 2023-09-01

Press Mentions

'Triple-Threat' Approach Reduces Life-Threatening Central Line Infections in Children with CancerJanuary 29th, 2016
Failure of Intravenous Pentamidine Prophylaxis to Prevent Pneumocystis Pneumonia in a Pediatric Hematopoietic Stem Cell Transplant (HSCT) PatientFebruary 28th, 2017